Search - tctmd.com

Displaying 101 - 120 of 264

Sort: Relevancy | Date

News Daily News

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Nicole Lou

June 16, 2015

News Daily News

Con los SLF de Nueva Generación, la Implantación de Stents Ultralargos se asoció a Episodios Adversos

Nicole Lou

June 16, 2015

News Daily News

Un Meta Análisis Confirma la Seguridad Tardía de los SLF de 2ª Generación

L.A. McKeown

June 10, 2015

News Daily News

Meta-analysis Confirms Late Safety of Second-Generation DES

L.A. McKeown

June 10, 2015

News Daily News

Meta 分析证实了第二代 DES 的晚期安全性

L.A. McKeown

June 10, 2015

Presentation EuroPCR 2015

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Presenter: Sigmund Silber

May 19, 2015

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Industry News

Medtronic to Initiate Clinical Study of Drug-Filled Stent Following Successful Preclinical Results

March 14, 2015

News Industry News

Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting Stent in United States

March 12, 2015

News Daily News

SECURITY: 6 Months of DAPT Noninferior to 12 Months in Low-Risk Patients After PCI

Yael L. Maxwell

November 17, 2014

News Daily News

SECURITY: 6 Meses de Terapia Antiplaquetaria Doble No son Inferiores a 12 Meses en Pacientes de Bajo Riesgo Post-PCI

Yael L. Maxwell

November 17, 2014

News Daily News

SECURITY：在PCI后的低风险患者中，6个月DAPT相对于12个月的该策略具有非劣效性

Yael L. Maxwell

November 17, 2014

News Daily News

研究证实采用较新DES时支架内血栓形成和心肌梗死风险降低

Salynn Boyles

November 02, 2014

News Daily News

Un Estudio Confirma Menor Riesgo de Trombosis del Stent,IM con los Nuevos SLF

Salynn Boyles

November 02, 2014

News Daily News

TWENTE: Second-Generation DES Show Good Long-term Outcomes in Bifurcation Lesions

L.A. McKeown

November 02, 2014

News Daily News

TWENTE: los SLF de 2ª Generación tienen Buenos Resultados a Largo Plazo en Lesiones en Bifurcación

L.A. McKeown

November 02, 2014

News Daily News

TWENTE：第二代DES在分叉病变中表现出良好的长期结果

L.A. McKeown

November 02, 2014

News Daily News

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

Salynn Boyles

November 02, 2014

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent Following CE Mark

November 02, 2014

Presentation

Three-Year Clinical Outcome of Patients With Bifurcation Treatment With Second-Generation Resolute and Xience V Stents

Presenter: M.K. Lam

October 31, 2014

Advertisement

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Con los SLF de Nueva Generación, la Implantación de Stents Ultralargos se asoció a Episodios Adversos

Un Meta Análisis Confirma la Seguridad Tardía de los SLF de 2ª Generación

Meta-analysis Confirms Late Safety of Second-Generation DES

Meta 分析证实了第二代 DES 的晚期安全性

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Evolving DES Technology May Benefit Diabetic Patients

Medtronic to Initiate Clinical Study of Drug-Filled Stent Following Successful Preclinical Results

Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting Stent in United States

SECURITY: 6 Months of DAPT Noninferior to 12 Months in Low-Risk Patients After PCI

SECURITY: 6 Meses de Terapia Antiplaquetaria Doble No son Inferiores a 12 Meses en Pacientes de Bajo Riesgo Post-PCI

SECURITY：在PCI后的低风险患者中，6个月DAPT相对于12个月的该策略具有非劣效性

研究证实采用较新DES时支架内血栓形成和心肌梗死风险降低

Un Estudio Confirma Menor Riesgo de Trombosis del Stent,IM con los Nuevos SLF

TWENTE: Second-Generation DES Show Good Long-term Outcomes in Bifurcation Lesions

TWENTE: los SLF de 2ª Generación tienen Buenos Resultados a Largo Plazo en Lesiones en Bifurcación

TWENTE：第二代DES在分叉病变中表现出良好的长期结果

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent Following CE Mark

Three-Year Clinical Outcome of Patients With Bifurcation Treatment With Second-Generation Resolute and Xience V Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content